Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery-Reference-Cited by-同舟云学术

Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery

Published:2019-07-25 Issue:14 Volume:20 Page:1703-1709
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Wentz Scott M¹,Price Francis²,Harris Alon¹,Siesky Brent¹,Ciulla Thomas¹³⁴

Affiliation:

1. Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA

2. Price Vision Group, Indianapolis, IN, USA

3. Midwest Eye Institute, Indianapolis, IN, USA

4. Clearside Biomedical, Alpharetta, GA, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2019.1645834

Reference48 articles.

1. Lindstrom R Thoughts on cataract surgery: 2015: review of opthalmology; 2015 cited 2018 Sep 20. Available from: https://www.reviewofophthalmology.com/article/thoughts-on–cataract-surgery-2015

2. Pseudophakic Cystoid Macular Edema

3. Cystoid Macular Edema and Papilledema Following Cataract Extraction

4. A Newly Defined Vitreous Syndrome Following Cataract Surgery*

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects;Journal of Nanobiotechnology;2023-07-22

2. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases;Journal of Controlled Release;2023-02

3. Immune modulating nanoparticles for the treatment of ocular diseases;Journal of Nanobiotechnology;2022-11-24

4. Drug-eluting intraocular lens with sustained bromfenac release for conquering posterior capsular opacification;Bioactive Materials;2022-03

5. Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets;Drugs;2022-01-13